US Pharma MarketingCDA data reveals trends on drug approvals and reimbursements in Canada - Pharmaceutical Technology
In April 2026, Canada’s Drug Agency released an expanded data set offering insights within its regulatory system for drug approvals and reimbursement in Canada. According to GlobalData POLI, the average time to reimburse in Canada for all branded drugs has steadily increased. In 2024, the expanded dataset showed that 111 drugs had received Health Canada approval. Credit: Lester Balajadia via Shutterstock.com. In April 2026, Canada’s Drug Agency (CDA) released an expanded data set offering insights and trends within its regulatory system for drug approvals and reimbursement in Canada. This is an expansion from CDA’s original set of data, which was…
In April 2026, Canada’s Drug Agency released an expanded data set offering insights within its regulatory system for drug approvals and reimbursement in Canada.
Source: Pharmaceutical Technology